{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:21:23Z","timestamp":1791325283815,"version":"4.3.1"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2024HXBH084"],"award-info":[{"award-number":["2024HXBH084"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752245"],"award-info":[{"award-number":["2024M752245"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["24ZDYF0293"],"award-info":[{"award-number":["24ZDYF0293"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["24ZDYF0224"],"award-info":[{"award-number":["24ZDYF0224"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024ZDYF0224"],"award-info":[{"award-number":["2024ZDYF0224"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024ZDYF0293"],"award-info":[{"award-number":["2024ZDYF0293"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jaut.2024.103286","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:39:57Z","timestamp":1721482797000},"page":"103286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-5651","authenticated-orcid":false,"given":"Changpei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2024.103286_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103286_bib2","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2024.103286_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.jaut.2024.103286_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib5","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC international workshop","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.jaut.2024.103286_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2024.103286_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-021-05063-3","article-title":"The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registry","volume":"42","author":"Gupta","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2024.103286_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12891-022-05372-z","article-title":"Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort","volume":"23","author":"Yang","year":"2022","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103286_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis Project for inflammatory myopathies: an association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103286_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.27504","article-title":"Incidence and prevalence of immune\u2010mediated necrotizing myopathy in adults in Olmsted County, Minnesota","volume":"65","author":"Shelly","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103286_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2022.04.017","article-title":"Epidemiological and genetic features of anti-3-hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: single-center experience and literature review","volume":"101","author":"Prieto-Pe\u00f1a","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103286_bib17","article-title":"Pediatric immune-mediated necrotizing myopathy","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103286_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103286_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/tan.14950","article-title":"Association of immune\u2010mediated necrotizing myopathy with HLA polymorphisms","volume":"101","author":"Ohnuki","year":"2023","journal-title":"Hla"},{"key":"10.1016\/j.jaut.2024.103286_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2024.103286_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2024.103286_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141616","article-title":"Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"10","author":"Ge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2024.103286_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2024.103286_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-248880","article-title":"Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy","volume":"15","author":"Adler","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jaut.2024.103286_bib27","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","article-title":"Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies","volume":"34","author":"Leff","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib28","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.2169\/internalmedicine.2551-23","article-title":"New-onset immune-mediated necrotizing myopathy and trigeminal neuropathy after SARS-CoV-2 mRNA vaccination in a patient with rheumatoid arthritis and sj\u00f6gren's syndrome","volume":"62","author":"Tsuzuki Wada","year":"2023","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.jaut.2024.103286_bib29","article-title":"Immune-mediated necrotizing myopathy with concurrent statin use after routine COVID-19 inoculation: a case report","volume":"15","author":"Mufti","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2024.103286_bib30","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1002\/mus.27531","article-title":"A temporal association between COVID-19 vaccination and immune-mediated necrotizing myopathy","volume":"65","author":"Tan","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103286_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/299691a0","article-title":"Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum","volume":"299","author":"Walter","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2024.103286_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1802252115","article-title":"Sequential activation of human signal recognition particle by the ribosome and signal sequence drives efficient protein targeting","volume":"115","author":"Lee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2024.103286_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113936","article-title":"The pathogenesis of anti-signal recognition particle necrotizing myopathy: a Review","volume":"156","author":"Qiu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jaut.2024.103286_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2958.2004.04139.x","article-title":"A structural step into the SRP cycle","volume":"53","author":"Wild","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jaut.2024.103286_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2024.103286_bib36","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"Friesen","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.jaut.2024.103286_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/ar4468","article-title":"Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies","volume":"16","author":"Drouot","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2024.103286_bib39","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.40883","article-title":"Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity","volume":"71","author":"Pinal-Fernandez","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib40","first-page":"e507","article-title":"Necrosis in anti-SRP+ and anti-HMGCR+myopathies","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2024.103286_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-018-0763-z","article-title":"Potential pathogenic role of anti-signal recognition protein and anti-3-hydroxy-3-methylglutaryl-CoA reductase antibodies in immune-mediated necrotizing myopathies","volume":"20","author":"Ladislau","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2024.103286_bib42","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","article-title":"Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology","volume":"2","author":"Alshehri","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.jaut.2024.103286_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.autrev.2018.09.008","article-title":"Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy","volume":"18","author":"Anquetil","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103286_bib44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib45","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2024.103286_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777502","article-title":"Belimumab for immune-mediated necrotizing myopathy associated with anti-SRP antibodies: a case report and retrospective review of patients treated with anti-B-cell therapy in a single center and literature","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib47","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/rheumatology\/keab629","article-title":"Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series","volume":"61","author":"Zhang","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib48","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1097\/RHU.0000000000001786","article-title":"Role of intravenous immunoglobulin in necrotizing autoimmune myopathy","volume":"28","author":"Kocoloski","year":"2022","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","article-title":"Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM)","volume":"264","author":"Rojana-udomsart","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2024.103286_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2018-213518","article-title":"In vivopathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy","volume":"78","author":"Bergua","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103286_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib52","article-title":"Jo-1 antibodies from myositis induce complement-dependent cytotoxicity and TREM-1 upregulation in muscle endothelial cells","volume":"10","author":"Honda","year":"2023","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.jaut.2024.103286_bib53","article-title":"Comprehensive transcriptomic analysis and machine learning reveal unique gene expression profiles in patients with immune-mediated necrotizing myopathy","author":"Liu","year":"2023","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jaut.2024.103286_bib54","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/rheumatology\/keab900","article-title":"Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy","volume":"61","author":"Lia","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib55","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1212\/NXI.0000000000000558","article-title":"PD1 pathway in immune-mediated myopathies","volume":"6","author":"Knauss","year":"2019","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"key":"10.1016\/j.jaut.2024.103286_bib56","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200143","article-title":"Upregulation of the cd155-CD226 Axis is associated with muscle inflammation and disease severity in idiopathic inflammatory myopathies","volume":"10","author":"Li","year":"2023","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"key":"10.1016\/j.jaut.2024.103286_bib57","article-title":"TCR\u03b2 clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activity","volume":"14","author":"Anang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577833","article-title":"Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy","volume":"365","author":"Oda","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2024.103286_bib59","article-title":"Interleukin-6 trans-signaling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy","author":"Ma","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib60","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1093\/rheumatology\/kead108","article-title":"TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair","volume":"62","author":"Yang","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24631","article-title":"Activation of cGAS-STING pathway - a possible cause of myofiber atrophy\/necrosis in dermatomyositis and immune-mediated necrotizing myopathy","volume":"36","author":"Zhou","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jaut.2024.103286_bib62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1158\/2326-6066.CIR-17-0263","article-title":"TNF\u03b1 and radioresistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in nonimmunogenic tumors","volume":"6","author":"Francica","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jaut.2024.103286_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.791986","article-title":"Endoplasmic reticulum stress is involved in muscular pathogenesis in idiopathic inflammatory myopathies","volume":"10","author":"Ma","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jaut.2024.103286_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13084","article-title":"Endoplasmic reticulum-stress and unfolded protein response-activation in immune-mediated necrotizing myopathy","volume":"32","author":"Preusse","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2024.103286_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2024.103286_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26608","article-title":"Autophagy markers LC3 and p62 accumulate in immune\u2010mediated necrotizing myopathy","volume":"60","author":"Girolamo","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103286_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nmd.2018.01.004","article-title":"Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies","volume":"28","author":"Matsubara","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib68","article-title":"miR-18a-3p and its target protein HuR may regulate myogenic differentiation in immune-mediated necrotizing myopathy","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib69","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3390\/cells12172198","article-title":"Identification of unique microRNA profiles in different types of idiopathic inflammatory myopathy","volume":"12","author":"Mu\u00f1oz-Braceras","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2024.103286_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1032738","article-title":"The accumulation of muscle RING finger-1 in regenerating myofibers: implications for muscle repair in immune-mediated necrotizing myopathy","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25041967","article-title":"Extracellular vesicles in the pathogenesis, clinical characterization, and management of dermatomyositis: a narrative review","volume":"25","author":"Ricco","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2024.103286_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.imlet.2009.12.018","article-title":"Increased serum concentration of immune cell derived microparticles in polymyositis\/dermatomyositis","volume":"128","author":"Baka","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2024.103286_bib73","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mus.21311","article-title":"Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients","volume":"39","author":"Shirafuji","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103286_bib74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/BOR.0000000000000748","article-title":"Nonimmune mechanisms in idiopathic inflammatory myopathies","volume":"32","author":"Loredo Martinez","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acs.jproteome.2c00532","article-title":"Proteomics analysis of plasma-derived exosomes unveils the aberrant complement and coagulation cascades in dermatomyositis\/polymyositis","volume":"22","author":"Meng","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2024.103286_bib76","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-018-0682-0","article-title":"Molecular interactions at the surface of extracellular vesicles","volume":"40","author":"Buz\u00e1s","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103286_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00281-005-0004-1","article-title":"Emission of membrane vesicles: roles in complement resistance, immunity and cancer","volume":"27","author":"Pilzer","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2024.103286_bib78","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.7150\/thno.59152","article-title":"Plasma-derived DNA containing-extracellular vesicles induce STING-mediated proinflammatory responses in dermatomyositis","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jaut.2024.103286_bib79","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1601093","article-title":"Chemorepellent semaphorin 3E negatively regulates neutrophil migration in vitro and in vivo","volume":"198","author":"Movassagh","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib80","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.4049\/jimmunol.1003464","article-title":"Plexin-D1 is a novel regulator of germinal centers and humoral immune responses","volume":"186","author":"Holl","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib81","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/rheumatology\/keab588","article-title":"Identification of plexin D1 on circulating extracellular vesicles as a potential biomarker of polymyositis and dermatomyositis","volume":"61","author":"Uto","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1243512","article-title":"Gut microbiota dysbiosis characterized by abnormal elevation of Lactobacillus in patients with immune-mediated necrotizing myopathy","volume":"13","author":"Liang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jaut.2024.103286_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2024.103286_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew470","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","author":"Tiniakou","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.670784","article-title":"The clinicopathological distinction between seropositive and seronegative immune-mediated necrotizing myopathy in China","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12891-023-06354-5","article-title":"Anti-signal recognition particle positive necrotizing myopathy-sjogren\u2019s syndrome overlap syndrome: a descriptive study on clinical and myopathology features","volume":"24","author":"Xu","year":"2023","journal-title":"BMC Muscoskel. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib87","article-title":"Chronic anti-HMG-CoA reductase positive necrotizing myositis with remote exposure to statins","volume":"15","author":"Salar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2024.103286_bib88","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3390\/diagnostics11112064","article-title":"Prominent asymmetric muscle weakness and atrophy in seronegative immune-mediated necrotizing myopathy","volume":"11","author":"Park","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jaut.2024.103286_bib89","article-title":"A rare case of PL-7-associated immune-mediated necrotizing myopathy with isolated dysphagia as the presenting symptom","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2024.103286_bib90","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mus.27435","article-title":"Immune\u2010mediated necrotizing myopathy: unusual presentations of a treatable disease","volume":"64","author":"Nicolau","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2024.103286_bib91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nmd.2022.12.012","article-title":"A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis","volume":"33","author":"Sasaki","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib92","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231181336","article-title":"Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy","volume":"15","author":"Ge","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jaut.2024.103286_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102465","article-title":"Anti-RNP antibodies delineate a subgroup of myositis: a systematic retrospective study on 46 patients","volume":"19","author":"Wesner","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103286_bib94","article-title":"Characteristics of cardiac involvement in immune-mediated necrotizing myopathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib95","article-title":"Evidence of cardiac involvement in a patient with necrotizing autoimmune myopathy (NAM)","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2024.103286_bib96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12890-021-01802-1","article-title":"Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies","volume":"22","author":"Ge","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jaut.2024.103286_bib97","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/RHU.0000000000002043","article-title":"Analytic and clinical validity of myositis-specific antibodies by line-blot immunoassay is essential","volume":"30","author":"Tseng","year":"2024","journal-title":"J. Clin. Rheumatol. : practical reports on rheumatic & musculoskeletal diseases"},{"key":"10.1016\/j.jaut.2024.103286_bib98","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2169\/internalmedicine.0303-17","article-title":"Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody","volume":"57","author":"Kusumoto","year":"2018","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.jaut.2024.103286_bib99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2024.103286_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217096","article-title":"Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies","volume":"81","author":"Yang","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103286_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102691","article-title":"Cutaneous involvement in anti-HMGCR positive necrotizing myopathy","volume":"123","author":"Williams","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103286_bib102","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1007\/s10072-022-06279-2","article-title":"A case of meningoencephalomyelitis associated with immune-mediated necrotizing myopathy","volume":"43","author":"Chen","year":"2022","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jaut.2024.103286_bib103","first-page":"212","article-title":"Anti-SRP myopathy with sensorimotor polyneuropathy: a case report","volume":"32","author":"Huang","year":"2023","journal-title":"Acta Neurol. Taiwan"},{"key":"10.1016\/j.jaut.2024.103286_bib104","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12959-021-00347-x","article-title":"Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature","volume":"19","author":"Li","year":"2021","journal-title":"Thromb. J."},{"key":"10.1016\/j.jaut.2024.103286_bib105","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.14942","article-title":"Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy","volume":"27","author":"Sakai","year":"2024","journal-title":"International journal of rheumatic diseases"},{"key":"10.1016\/j.jaut.2024.103286_bib106","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2024.103286_bib107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/keac144","article-title":"Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation","volume":"62","author":"Shelly","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib108","article-title":"Immune-mediated necrotizing myopathy in a patient with microscopic polyangiitis: a case report","author":"Umemoto","year":"2023","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"10.1016\/j.jaut.2024.103286_bib109","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.nmd.2022.05.011","article-title":"256th ENMC international workshop: myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021","volume":"32","author":"Damoiseaux","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/405956","article-title":"Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies","volume":"2014","author":"Musset","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaut.2024.103286_bib111","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12026-016-8867-x","article-title":"Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure","volume":"65","author":"Shovman","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2024.103286_bib112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2017.07.011","article-title":"Detection of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase by ELISA in a reference laboratory setting","volume":"472","author":"Jaskowski","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2024.103286_bib113","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/RHU.0000000000002015","article-title":"Clinical characteristics and prognostic value of Ro52\/SSA antibodies in idiopathic inflammatory myopathies","volume":"29","author":"Pepper","year":"2023","journal-title":"J. Clin. Rheumatol. : practical reports on rheumatic & musculoskeletal diseases"},{"key":"10.1016\/j.jaut.2024.103286_bib114","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s40001-023-01363-5","article-title":"What should we expect when two myositis-specific antibodies coexist in a patient","volume":"28","author":"Zheng","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.jaut.2024.103286_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102993","article-title":"Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge","volume":"21","author":"Merlonghi","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2024.103286_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2024.103286_bib117","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00415-022-11447-7","article-title":"Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies","volume":"270","author":"Fionda","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nmd.2021.10.007","article-title":"Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy","volume":"32","author":"Kubota","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jaut.2024.103286_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250326","article-title":"Toll-like receptors and IL-7 as potential biomarkers for immune-mediated necrotizing myopathies","volume":"53","author":"Cappelletti","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2044-5040-1-10","article-title":"Muscle membrane repair and inflammatory attack in dysferlinopathy","volume":"1","author":"Han","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.jaut.2024.103286_bib121","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0028-3886.43447","volume":"56","author":"Urtizberea","year":"2008","journal-title":"Neurol. India"},{"key":"10.1016\/j.jaut.2024.103286_bib122","first-page":"321","article-title":"Differences in muscle magnetic resonance imaging findings between anti-signal recognition particle antibody-positive myopathy and anti-aminoacyl-tRNA synthetase antibody-positive myositis","volume":"42","author":"Kimura","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1251025","article-title":"Machine learning-based radiomics to differentiate immune-mediated necrotizing myopathy from limb-girdle muscular dystrophy R2 using MRI","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2024.103286_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/WNL.0000000000001767","article-title":"Plasma IP-10 level distinguishes inflammatory myopathy","volume":"85","author":"Uruha","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2024.103286_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13101369","article-title":"Retrospective study shows that serum levels of chemokine CXCL10 and cytokine GDF15 support a diagnosis of sporadic inclusion body myositis and immune-mediated necrotizing myopathy","volume":"13","author":"De Paepe","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.jaut.2024.103286_bib126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.55563\/clinexprheumatol\/2ao5ze","article-title":"Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data","volume":"40","author":"Rademacher","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib127","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1093\/rheumatology\/keac014","article-title":"Outcome predictors of immune-mediated necrotizing myopathy\u2014a retrospective, multicentre study","volume":"61","author":"Wang","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib128","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1093\/rheumatology\/kead424","article-title":"Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab","volume":"63","author":"Wen","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1301109","article-title":"Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103286_bib130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315990121","article-title":"Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy","volume":"121","author":"Qin","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2024.103286_bib131","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3390\/biomedicines10082036","article-title":"Prevention of anti-HMGCR immune-mediated necrotising myopathy by C5 complement inhibition in a humanised mouse model","volume":"10","author":"Julien","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaut.2024.103286_bib132","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/S2665-9913(23)00003-6","article-title":"Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial","volume":"5","author":"Mammen","year":"2023","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib133","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1093\/rheumatology\/kead298","article-title":"Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy","volume":"62","author":"Julien","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib134","article-title":"The efficacy of tocilizumab in the treatment of patients with refractory immune-mediated necrotizing myopathies: an open-label pilot study","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2024.103286_bib135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.46497\/ArchRheumatol.2023.9257","article-title":"Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis","volume":"38","author":"de Oliveira","year":"2023","journal-title":"Archives of rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib136","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/14397595.2016.1213480","article-title":"The effects of bolus supplementation of branched-chain amino acids on skeletal muscle mass, strength, and function in patients with rheumatic disorders during glucocorticoid treatment","volume":"27","author":"Yoshikawa","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103286_bib137","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1093\/rheumatology\/keac101","article-title":"Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II\/III, multi-centre, randomized controlled trial","volume":"61","author":"Kimura","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103286_bib138","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejim.2023.05.011","article-title":"Therapeutic challenges and cardiovascular risk in patients with HMGCR-associated immune-mediated necrotizing myopathy (HMGR-IMNM) secondary to statins","volume":"114","author":"\u00c1lvarez-Troncoso","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2024.103286_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/6550473","article-title":"Statin-induced necrotizing autoimmune myopathy: case report of a patient under chronic treatment","volume":"2023","author":"Bellofatto","year":"2023","journal-title":"Case Reports in Medicine"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:36:13Z","timestamp":1778546173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":139,"alternative-id":["S0896841124001203"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103286","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103286"}}